Image by Freepik
A team of medical experts from Montefiore Medical Center and Albert Einstein College of Medicine in New York discovered that cardiac donors infected with the SARS-CoV-2 virus increase mortality risk for recipients. The scientists analyzed data from the United Network for Organ Sharing (UNOS) database relating to COVID-19 in their study, which was published in the Journal of the American College of Cardiology.
Previous autopsy research has revealed that, while transmissible SARS-CoV-2 viruses are mostly detected in the respiratory tract, proteins linked to the virus can be identified in other areas of the body, including the heart. The researchers behind this new initiative investigated the impact of heart transplants from COVID-19-infected patients who died from other causes (most commonly head trauma).
The researchers examined UNOS data for instances of cardiac donors who were also discovered to be infected with the SARS-CoV-2 virus from May 2020 to June 2022. They also collected information from donors who had been infected prior to donation but had recovered before death.
In total, the researchers discovered 150 donors who were infected at the time of death and 87 who died not long after recovering from an infection. They also gathered information on similar patient types from donors who had no history of infection.
When they examined their data, they discovered that patients who received a heart from an infected donor had a 13.8% mortality rate at six months, compared to 4.9% for those who had not been infected. The rates after one year were 23.2% and 9.2%, respectively. The researchers also discovered that the rate disparities in patients receiving hearts from donors who had recovered from their infections before donating were essentially equal to those in patients receiving hearts from donors who had never been sick.
Based on their findings, the team concludes that donors should be checked for COVID-19 before donating a heart or any other organ.
more recommended stories
Shingles Vaccine May Cut Dementia Risk by 20%A new study shows that the.
New Study Questions Fluid Restriction in Heart Failure ManagementA groundbreaking study presented at the.
Role of Leptin Signaling in the DMH for Metabolic RegulationA groundbreaking study from the Pennington.
COVID-19 Vaccines May Lower the Risk of Long COVID by 27%A recent rapid review suggests that.
3D-Printed Hydrogel for Meniscus Tear TreatmentMeniscus tears are one of the.
Machine Learning Predicts Early Mortality in IBD PatientsA groundbreaking study published in the.
Endometriosis Treatment Advances: Latest Research and TherapyRecent endometriosis treatment advances are reshaping.
Lung Cancer Screening Gaps Persist Despite Updated GuidelinesA recent study led by researchers.
Altered Knee Movement After ACL Surgery May Trigger Early OsteoarthritisA recent study published in the.
BRP Peptide for Weight Loss: A Natural Alternative to Ozempic?The rising obesity epidemic has fueled.
Leave a Comment